MedPath

The effect of misoprostol and oxytocin in the treatment of placenta retaining

Phase 3
Conditions
Relation the effects of misoprostol and oxytocin in the treatment of placenta.
Registration Number
IRCT2015102824754N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
44
Inclusion Criteria

During the first and second stages of labor with success, leaving the pair within half an hour after leaving the fetus from the uterus, to obtain written consent from patients to participate in the study
Exclusion criteria:
Maternal and fetal problems that lead to vaginal delivery is possible. ; Placenta within half an hour after leaving the fetus from the uterus, patient request for exclusion

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Withdrawal time of placenta. Timepoint: 30 minutes. Method of measurement: According on minutes.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath